Eli Lilly and Company (LLY) New York Stock Exchange
116.79-0.02-0.02%
CloseMay 24, 2019

News: updated – 25-May 12:30


FDA OKs Novocure’s TTF for mesothelioma under HDE status; shares up 4% after hours23-May 04:30(SeekingAlpha)

The FDA approves Novocure’s (NASDAQ: NVCR ) NovoTTF-100L System, combined with Eli Lilly’s (NYSE: LLY ) Alimta (pemetrexed) and platinum-based chemo, for the first-line treatment of locally advanced or metastatic malignant pleural mesothelioma (MPM). More news on: NovoCure Limited, …

Bulletproof Investing Performance Update: Week 7823-May 03:05(SeekingAlpha)

Safety First: NASCAR driver Johanna Long and her helmet (Image Credit: Gearheads ) Bulletproof Investing: Week 78 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. T…